I think it was something around having to do a trial on certain cancers to get info about FTO to then be able to do a targeted FTO trial. As they were in a catch 22. They couldn’t run a purely FTO trial in humans without data proving the effect of Bisantrene on FTO. So they are running a trial on melanoma and CCRC to get the data necessary for the FTO targeted trial.
(apologies if I’m way off but that was the way I understood it. Which doesn’t necessarily mean much haha)
With the FTO expression so high in Melanoma I’d say this is why it was chosen.
- Forums
- ASX - By Stock
- RAC
- Ann: Race Initiates FTO Melanoma Preclinical Study
Ann: Race Initiates FTO Melanoma Preclinical Study, page-29
-
-
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.66 |
Change
0.000(0.00%) |
Mkt cap ! $282.8M |
Open | High | Low | Value | Volume |
$1.68 | $1.68 | $1.62 | $102.7K | 62.79K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 359 | $1.65 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.66 | 249 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 359 | 1.645 |
1 | 48323 | 1.640 |
1 | 10000 | 1.615 |
1 | 19208 | 1.610 |
3 | 20625 | 1.600 |
Price($) | Vol. | No. |
---|---|---|
1.660 | 249 | 1 |
1.680 | 5000 | 1 |
1.720 | 580 | 1 |
1.730 | 25792 | 1 |
1.750 | 508 | 1 |
Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |